Bone Findings in Transplant Recipients With Gout

The PROTECT study examined pegloticase safety and efficacy in immunosuppressed kidney transplant recipients with uncontrolled gout. A subset of patients underwent dual-energy CT to examine bone and soft tissue abnormalities. A poster presented at ASN Kidney Week (“Dual-Energy CT Bone Findings in Kidney Transplant Recipients With Uncontrolled Gout”) by Abdul Abdellatif, MD, and others reported these bone-related findings. Joel Topf, MD, of Nephrology Times caught up with Dr. Abdellatif to discuss the findings.